Previous 10 | Next 10 |
NEWS RELEASE – REGULATED INF O RMATION 20 JANUARY 202 3 , 1 : 0 0 a m ET / 7 : 0 0 am CET MDxHealth Provides Update d and Supplemental Financial Information ...
NEWS RELEASE – INSIDE AND REGULATED INF O RMATION 9 JANUARY 202 3 , 4 PM ET / 22 :00 CET MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue Guidance IRVINE, CA,...
MDxHealth SA press release ( NASDAQ: MDXH ): Q2Revenue of $6.9M. The Company ended the second quarter dated June 30, 2022, with a cash and cash equivalents balance of $40.0 million For further details see: MDxHealth SA reports Q2 results
Gainers: Allarity Therapeutics (ALLR) +13%. Better Therapeutics (BTTX) +19%. GeoVax Labs GOVX +10%. Insulet PODD +7%. MDxHealth (MDXH) +5%. Losers: INmune Bio (INMB) -29%. Liquidia (LQDA) -21%. TherapeuticsMD (TXMD) -19%. Aethlon Medical (AEMD) -14%....
Gainers: Lixiang Education Holding (LXEH) +62%. GeoVax Labs (GOVX) +50%. Sonder Holdings (SOND) +30%. O2Micro International (OIIM) +30%. Evolving Systems (OTC:EVOL) +28%. GoldMining (GLDG) +27%. Neonode (NEON) +24%. Mesa Royalty Trust (MTR) +24%. TRxADE HEALTH (MEDS) +23%. Losers: HIVE Blockc...
Gainers: Immix Biopharma (IMMX) +48%. MDxHealth (MDXH) +31%. ClearPoint Neuro (CLPT) +16%. Covetrus (CVET) +14%. Kronos Bio (KRON) +13%. Losers: Evofem Biosciences (EVFM) -58%. Bright Green (BGXX) -26%. Foghorn Therapeutics (FHTX) -19%. N...
MDxHealth SA press release (NASDAQ:MDXH): Q1 GAAP EPS of -$0.05 beats by $0.47. Revenue of $6.11M (+20.8% Y/Y) beats by $0.1M. For further details see: MDxHealth SA GAAP EPS of -$0.05 beats by $0.47, revenue of $6.11M beats by $0.1M
MDxHealth SA (MXDHF) Q4 2021 Earnings Conference Call March 2, 2022, 4:30 PM ET Company Participants Michael McGarrity – Chief Executive Officer Ron Kalfus – Chief Financial Officer Conference Call Participants Jason Bednar – Piper Sandler Kevin DeGeeter – Oppenhei...
MDxHealth SA press release (NASDAQ:MDXH): FY GAAP EPS of -$0.24 beats by $1.90. Revenue of $22.24M (+20.5% Y/Y) misses by $0.53M. For further details see: MDxHealth SA GAAP EPS of -$0.24 beats by $1.90, revenue of $22.24M misses by $0.53M
Gainers: Aerie Pharmaceuticals (NASDAQ:AERI) +25%. Schrodinger (NASDAQ:SDGR) +17%. MDxHealth (NASDAQ:MDXH) +16%. Lantheus (NASDAQ:LNTH) +13%. Tabula Rasa HealthCare (NASDAQ:TRHC) +13%. Losers: Baudax Bio BXRX -55%. The Joint (NASDAQ:JYNT) -15%. Biohaven...
News, Short Squeeze, Breakout and More Instantly...
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced the appoin...
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today reported prelimi...
Mdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 ( GlobeNewswire ) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, ...